Home>Topics>Companies>Allergan

Allergan AGN

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant

      Headlines

      Mon, 20 Oct 2014

      BOSTON (Reuters) - Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc ., and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer David Pyott tried to discredit Valeant as it was

    2. Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant

      Headlines

      Mon, 20 Oct 2014

      BOSTON, Oct 20 (Reuters) - Billionaire investor William Ackman, whose fund is the largest shareholder in Allergan Inc . , and Valeant Pharmaceuticals said the botox maker's Chief Executive Officer...

    3. Top Allergan holder Paulson urges deal with Shire: sources

      Headlines

      Mon, 20 Oct 2014

      (Reuters) - Allergan Inc shareholder Paulson & Co is urging the Botox maker to merge with specialty pharmaceutical company Shire Plc as an alternative to a deal with hostile bidder Valeant Pharmaceuticals International Inc , according to two people familiar with the matter.

    4. UPDATE 2-Top Allergan holder Paulson urges deal with Shire -sources

      Headlines

      Mon, 20 Oct 2014

      (Adds details on Paulson shareholdings in Allergan and Shire, background)

    5. Valeant says may raise Allergan bid; beats on profit

      Headlines

      Mon, 20 Oct 2014

      (Reuters) - Valeant Pharmaceuticals International Inc VRX.TO VRX.N said on Monday that it may raise its bid for Botox maker Allergan Inc AGN .N after the Canadian company posted a better-than-expected quarterly profit.

    6. UPDATE 3-Valeant says may raise Allergan bid; beats on profit

      Headlines

      Mon, 20 Oct 2014

      (Adds comment on potential rival bids, no comment from Allergan , updates stock prices)

    7. Valeant may raise Allergan bid, says it won't walk away

      Headlines

      Mon, 20 Oct 2014

      (Reuters) - Valeant Pharmaceuticals Inc may raise its hostile takeover bid for Allergan Inc and will not walk away from its pursuit ahead of Allergan 's Dec. 18 special shareholder meeting, Chief Executive Michael Pearson said on Monday.

    8. Valeant may raise Allergan bid, says it won't walk away

      Headlines

      Mon, 20 Oct 2014

      Oct 20 (Reuters) - Valeant Pharmaceuticals Inc may raise its hostile takeover bid for Allergan Inc and will not walk away from its pursuit ahead of Allergan 's Dec. 18 special shareholder meeting, Chief Executive Michael Pearson said on Monday.

    9. Drugmaker Valeant reports better-than-expected profit

      Headlines

      Mon, 20 Oct 2014

      Oct 20 (Reuters) - Canada's Valeant Pharmaceuticals International Inc , embroiled in a bitter fight to take over Botox-maker Allergan Inc , posted a better-than-expected quarterly profit, helped by strong sales in all its markets.

    10. Valeant Proves It Can Perform Without Acquisitions, Raises 2015 Guidance

      Commentary

      Mon, 20 Oct 2014

      While all attention remains on the pending Allergan acquisition, Valeant Pharmaceuticals' underlying business ..... not expect any changes to our moat rating. The drawn-out Allergan battle has forced Valeant to bring its acquisition strategy

    « Prev12345Next »
    Content Partners